Published online before print July 23, 2007, doi: 10.1161/HYPERTENSIONAHA.107.092049
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2007;50:519.)
© 2007 American Heart Association, Inc.
Original Articles |
Apoptosis Signal-Regulating Kinase-1 Is Involved in Vascular Endothelial and Cardiac Remodeling Caused by Nitric Oxide Deficiency
From the Department of Pharmacology and Molecular Therapeutics (T.Y., E.Y., K.K., T.N., S.M., Y.T., Y.-F.D., S.K.-M.) and Department of Cardiovascular Medicine (H.O.), Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan; and the Laboratory of Cell Signaling (H.I.), Graduate School of Pharmaceutical Sciences, University of Tokyo, Tokyo, Japan.
Correspondence to Shokei Kim-Mitsuyama, Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, 1-1-1 Honjyo, Kumamoto 860-8556, Japan. E-mail kimmitsu{at}gpo.kumamoto-u.ac.jp
Long-term treatment with N
-nitro-L-arginine methylester (L-NAME), an NO synthase inhibitor, induces hypertension and cardiovascular injury. However, its precise mechanism is unknown. Using apoptosis signal-regulating kinase-1 (ASK1)–deficient mice, we investigated the role of ASK1 in cardiovascular injury caused by L-NAME treatment. L-NAME was orally administered to ASK1-deficient and C57BL/6J (wild) mice for 8 weeks. L-NAME treatment increased blood pressure of wild and ASK1-deficient mice to a similar extent, indicating no role of ASK1 in NO-deficient hypertension. L-NAME treatment significantly impaired acetylcholine-induced carotid arterial relaxation in wild mice (P<0.01), being associated with the decreased endothelial NO synthase (eNOS) activity (P<0.01) and the increased disruption of eNOS dimer (P<0.01), whereas these changes by L-NAME were substantially attenuated in ASK1-deficient mice. Thus, ASK1 is involved in the impairment of vascular endothelial function by reducing eNOS activity and disrupting eNOS dimer. L-NAME treatment increased vascular reduced nicotinamide-adenine dinucleotide phosphate oxidase activity and superoxide in wild mice to a greater extent than in ASK1 deficient mice. L-NAME treatment in wild mice caused cardiac hypertrophy, myocyte apoptosis, macrophage infiltration, coronary arterial remodeling, interstitial fibrosis, and the expression of monocyte chemoattractant protein-1 and transforming growth factor-ß1, whereas these cardiac changes by L-NAME were absent in ASK1-deficient mice. Cardiac reduced nicotinamide-adenine dinucleotide phosphate oxidase activation and superoxide elevation by L-NAME were much less in ASK1-deficient mice than in wild mice. Our work provided the first evidence that ASK1 is implicated in vascular endothelial dysfunction and cardiovascular remodeling induced by NO deficiency by regulating eNOS and reduced nicotinamide-adenine dinucleotide phosphate oxidase.
Key Words: cardiovascular diseases • endothelium-derived relaxing factor • NO synthase • oxidative stress • signal transduction
This article has been cited by other articles:
 |
|
 |
|
  D. E. Stec, T. Vera, M. V. Storm, G. R. McLemore Jr, and M. J. Ryan Blood pressure and renal blow flow responses in heme oxygenase-2 knockout mice Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2009; 297(6): R1822 - R1828. [Abstract] [Full Text] [PDF]
|
|